NATIXIS ADVISORS, L.P. - SELECT SECTOR SPDR TR ownership

SELECT SECTOR SPDR TR's ticker is XLK and the CUSIP is 81369Y803. A total of 1,648 filers reported holding SELECT SECTOR SPDR TR in Q3 2023. The put-call ratio across all filers is 1.76 and the average weighting 0.7%.

Quarter-by-quarter ownership
NATIXIS ADVISORS, L.P. ownership history of SELECT SECTOR SPDR TR
ValueSharesWeighting
Q2 2023$1,739
-99.9%
10,002
-46.5%
0.01%
-58.3%
Q3 2019$1,504,000
+24.5%
18,680
+16.5%
0.01%
+9.1%
Q3 2018$1,208,000
-75.5%
16,037
-77.4%
0.01%
-54.2%
Q2 2018$4,932,000
+64.5%
70,996
+54.9%
0.02%
-20.0%
Q1 2018$2,999,000
+6.2%
45,836
+3.8%
0.03%
+3.4%
Q4 2017$2,825,000
-22.2%
44,179
-28.1%
0.03%
-23.7%
Q3 2017$3,630,000
+2.3%
61,434
-5.2%
0.04%0.0%
Q2 2017$3,548,000
+265.4%
64,837
+255.9%
0.04%
+245.5%
Q1 2017$971,000
-74.8%
18,220
-77.2%
0.01%
-76.1%
Q4 2016$3,858,000
+17.7%
79,772
+16.3%
0.05%
+9.5%
Q3 2016$3,277,000
-68.3%
68,583
-72.5%
0.04%
-76.9%
Q1 2015$10,352,000
-7.3%
249,796
-7.5%
0.18%
-12.9%
Q4 2014$11,163,000
-0.7%
269,965
-4.2%
0.21%
-7.5%
Q3 2014$11,245,000
+2.4%
281,834
-1.6%
0.23%
+43.9%
Q2 2014$10,982,000
-1.5%
286,373
-6.7%
0.16%
-8.7%
Q1 2014$11,154,000
-1.7%
306,860
-3.4%
0.17%
-7.5%
Q4 2013$11,347,000
+9.6%
317,497
-1.7%
0.19%
-2.6%
Q3 2013$10,352,000
-19.4%
323,101
-23.1%
0.19%
-25.4%
Q2 2013$12,846,000419,9340.26%
Other shareholders
SELECT SECTOR SPDR TR shareholders Q3 2023
NameSharesValueWeighting ↓
AGF Investments LLC 1,605,606$279,167,00023.49%
Mendel Capital Management LLC 106,854$18,579,00017.06%
McElhenny Sheffield Capital Management, LLC 206,563$35,915,00013.47%
WestEnd Advisors, LLC 2,631,269$457,498,810,00012.45%
5th Street Advisors, LLC 75,131$13,063,00012.39%
Biltmore Wealth Management, LLC 153,124$26,624,00010.02%
Conservest Capital Advisors, Inc. 535,749$93,151,0009.98%
Vickerman Investment Advisors, Inc. 140,548$24,437,0009.86%
Leicht Financial Planning & Wealth Management, Inc. 99,279$17,262,0009.85%
Capitol Family Office, Inc. 81,212$14,120,0009.69%
View complete list of SELECT SECTOR SPDR TR shareholders